Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Carpaij (Groningen, Netherlands), A. Faiz (Groningen, Netherlands), J. Boekhoudt (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), W. Timens (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), G. Tew (South San Fransisco, United States of America), G. Michele (South San Fransisco, United States of America), P. Hiemstra (Leiden, Netherlands), V. Guryev (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands). Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline. 4217

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Consensus network analysis reveals pathways associated with lung function decline in both COPD and IPF Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 308-309 Year: 2004 Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 307-308 Year: 2004 Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Longitudinal analysis of lung function decline with eosinophilic clustering in severe asthma Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time. Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomes Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients Source: International Congress 2018 – New developments in tuberculosis Year: 2018 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Late Breaking Abstract: Combining lung function and clinical severity score at two increases the predictability of current asthma at ten years Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Increased circulating fibrocytes associated with lung function decline in COPD patients with desaturation during 6 minute walk test Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth Source: International Congress 2018 – Prematurity and lung disease Year: 2018 Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Airway responsiveness predicts lung function decline differently in subjects with or without asthma: An international study Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Emphysema distribution determines distinct pulmonary function features Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013